AngioDynamics Inc logo

ANGO - AngioDynamics Inc Share Price

$12.01 1.4  13.4%

Last Trade - 05/06/20

Mid Cap
Market Cap £357.5m
Enterprise Value £347.4m
Revenue £201.9m
Position in Universe 2985th / 6325
Unlock ANGO Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the nine months ended 29 February 2020, AngioDynamics, Inc. revenues decreased 7% to $205.8M. Net loss before extraordinary items increased 12% to $9.7M. Revenues reflect United States segment decrease of 7% to $163.4M, International segment decrease of 4% to $42.4M. Higher net loss reflects Amortization of intangibles increase of 1% to $13.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ANGO Revenue Unlock ANGO Revenue

Net Income

ANGO Net Income Unlock ANGO Revenue

Normalised EPS

ANGO Normalised EPS Unlock ANGO Revenue

PE Ratio Range

ANGO PE Ratio Range Unlock ANGO Revenue

Dividend Yield Range

ANGO Dividend Yield Range Unlock ANGO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANGO EPS Forecasts Unlock ANGO Revenue
Profile Summary

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Last Annual May 31st, 2019
Last Interim February 29th, 2020
Incorporated July 30, 1992
Public Since May 27, 2004
No. of Shareholders: 180
No. of Employees: 750
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 37,694,757
Free Float (0.0%)
Eligible for
ANGO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ANGO
Upcoming Events for ANGO
Wednesday 8th July, 2020 Estimate
Q4 2020 AngioDynamics Inc Earnings Release
Thursday 1st October, 2020 Estimate
Q1 2021 AngioDynamics Inc Earnings Release
Wednesday 14th October, 2020 Estimate
AngioDynamics Inc Annual Shareholders Meeting
Frequently Asked Questions for AngioDynamics Inc
What is the AngioDynamics Inc share price?

As of 05/06/20, shares in AngioDynamics Inc are trading at $12.01, giving the company a market capitalisation of £357.5m. This share price information is delayed by 15 minutes.

How has the AngioDynamics Inc share price performed this year?

Shares in AngioDynamics Inc are currently trading at $12.01 and the price has moved by -37.02% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AngioDynamics Inc price has moved by -41.86% over the past year.

What are the analyst and broker recommendations for AngioDynamics Inc?

Of the analysts with advisory recommendations for AngioDynamics Inc, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for AngioDynamics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will AngioDynamics Inc next release its financial results?

AngioDynamics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-01
What is the AngioDynamics Inc dividend yield?

AngioDynamics Inc does not currently pay a dividend.

Does AngioDynamics Inc pay a dividend?

AngioDynamics Inc does not currently pay a dividend.

When does AngioDynamics Inc next pay dividends?

AngioDynamics Inc does not currently pay a dividend.

How do I buy AngioDynamics Inc shares?

To buy shares in AngioDynamics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AngioDynamics Inc?

Shares in AngioDynamics Inc are currently trading at $12.01, giving the company a market capitalisation of £357.5m.

Where are AngioDynamics Inc shares listed? Where are AngioDynamics Inc shares listed?

Here are the trading details for AngioDynamics Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ANGO
What kind of share is AngioDynamics Inc?

Based on an overall assessment of its quality, value and momentum, AngioDynamics Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a AngioDynamics Inc share price forecast 2020?

Shares in AngioDynamics Inc are currently priced at $12.01. At that level they are trading at 16.57% discount to the analyst consensus target price of 0.00.

Analysts covering AngioDynamics Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.087 for the next financial year.

How can I tell whether the AngioDynamics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AngioDynamics Inc. Over the past six months, the relative strength of its shares against the market has been -21.47%. At the current price of $12.01, shares in AngioDynamics Inc are trading at -12.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AngioDynamics Inc PE Ratio?

We were not able to find PE ratio data for AngioDynamics Inc.

Who are the key directors of AngioDynamics Inc?

AngioDynamics Inc's management team is headed by:

James Clemmer - PRE
Howard Donnelly - CHM
Brent Boucher - SVP
Chad Campbell - SVP
Warren Nighan - SVP
Eileen Auen - IND
David Helsel - SVP
Benjamin Davis - SVP
Kevin Gould - IND
Wesley Johnson - IND
Dennis Meteny - IND
Karen Licitra - IND
Kim Seabury - SVP
Stephen Trowbridge - CFO
Who are the major shareholders of AngioDynamics Inc?

Here are the top five shareholders of AngioDynamics Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 15.42% (5.81m shares)
Victory Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 12.74% (4.80m shares)
Victory Sycamore Small Company Opportunity Fund Mutual Fund
Percentage owned: 10.74% (4.05m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 8.3% (3.13m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.33% (2.38m shares)
Similar to ANGO
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.